Asia Pacific OTC Drug and Dietary Supplement Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Cough and Cold Products, Vitamins and Dietary Supplements, Analgesics, Gastrointestinal Products, Sleep Aids, Oral Care Products, Ophthalmic Products, Antacids, Feminine Care, and Others); Type (Branded, Generic); Form (Tablets, Capsules, Powders, Ointments, Liquid, and Others); Distribution Channel (Hospital and Retail Pharmacies, Retail Stores, Online Channels, and Others); and Country
Market Introduction
Over the counter (OTC) drugs are available for the public for their general use. These drugs do not require a prescription from a physician. OTC medicines are available for various medical symptoms due to medical conditions such as coughs and colds, diarrhea, heartburn, constipation, acne, pain, and others. On the other hand, dietary supplements are available over the counter for fitness purposes. Whereas, in some cases, when a person is critically ill or requires treatment, then buying a dietary supplement with medicinal ingredients requires a prescription from a physician. These OTC drugs and nutritional supplements have two type, such as branded or generic.
Get more information on this report : 
Market Overview and Dynamics
The Asia PacificOTC Drug and Dietary Supplementmarketis expected to reach US$ 96,156.8 million in 2027 from US$ 55,157.2 million in 2019. The market is anticipated to grow with a CAGR of 7.3% from 2020 to 2027. Factors driving the market growth include rising awareness among population about general health issues, and advantages of OTC drugs are expected to propel the growth of the market. However, stringent government regulation for OTC drugs is the major factor hindering the market growth. COVID19 has affected the Asia Pacific countries which has led to high number of coronavirus cases. People are purchasing more immunity booster products available in the market to combat coronavirus effect
Key Market Segments
In terms of product, the analgesicssegment held the largest share of the market in 2019; however, the vitamins and dietary supplementssegment is anticipated to register the highest CAGR in the market during the forecast period. In terms of type, the generic segment held a larger share of the market in 2019and similarsegment is estimated to register a higher market sharein the market during the forecast period. Likewise, in terms of form, the in tabletssegment held a larger share of the market in 2019 and is estimated to register a higher CAGR in the market during the forecast period. In terms of distribution channel hospital and retail pharmacies held the largest share of market in 2019: however, the online channels segment is anticipated to register the highest CAGR in the market during forecast period.
Major Sources and Companies Listed
The World Health Organization (WHO), World Heart Federation, National Center for Biotechnology Information Therapeutic Goods Administration are some of the major primary and secondary sources for the Asia PacificOTC drug and dietary supplement market included in the report.
Reasons to buy the report
- To understand the Asia PacificOTC drug and dietary supplement market landscape and identifymarket segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for the Asia PacificOTC drug and dietary supplement market
- Efficiently plan M&A and partnership dealsin the Asia PacificOTC drug and dietary supplement market by identifying market segments with the most promising probable sales
- Helps to takeknowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form the Asia PacificOTC drug and dietary supplement market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in the region
Asia Pacific OTC Drug and Dietary Supplement Market Segmentation
OTC drug and Dietary Supplement– By Product
- Cough and Cold Products
- Vitamins and Dietary Supplements
- Analgesics
- Gastrointestinal Products
- Sleep Aids
- Oral Care Products
- Ophthalmic Products
- Antacids
- Feminine Care
- Others
OTC Drug and Dietary Supplement – By Type
- Branded
- Generic
OTC Drug and Dietary Supplement – By Form
- Tablets
- Capsules
- Powders
- Ointments
- Liquid
- Others
OTC Drug and Dietary Supplement – By Distribution Channel
- Hospital and Retail Pharmacies
- Retail Stores
- Online Channels
- Others
By Country
- India
- China
- Japan
- Australia
- South Korea
CompanyProfiles
- GlaxoSmithKline plc.
- Sanofi
- Johnson and Johnson Services, Inc.
- Abbott
- AbbVie Inc.
- Bausch Health Companies Inc.
- Bayer AG
- Procter & Gamble
- Novartis AG
- Reckitt Benckiser Group Plc
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific OTC Drug and Dietary Supplement Market – By Product
1.3.2 Asia Pacific OTC Drug and Dietary Supplement Market – By Type
1.3.3 Asia Pacific OTC Drug and Dietary Supplement Market – By Form
1.3.4 Asia Pacific OTC Drug and Dietary Supplement – By Distribution Channel
1.3.5 Asia Pacific OTC Drug and Dietary Supplement Market– By Region
2. OTC Drug and Dietary Supplement Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. OTC Drug and Dietary Supplement – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific
4.3 Expert Opinion
5. Asia Pacific OTC Drug and Dietary Supplement Market – Industry Dynamics
5.1 Market Drivers
5.1.1 Rising General Health Issues
5.1.2 Preference for OTC Drugs
5.2 Market Restraints
5.2.1 Stringent Government Regulations For OTC Drugs
5.3 Market Opportunities
5.3.1 Business Expansion Activities by Market Players to Offer Improved OTC Drugs
5.4 Future Trends
5.4.1 Preference of OTC Drugs for Minor Diseases
5.5 Impact Analysis
6. OTC Drug and Dietary Supplement Market – Regional Analysis
6.1 Asia Pacific OTC Drug and Dietary Supplement Market Revenue Forecast And Analysis
7. Asia Pacific OTC Drug and Dietary Supplement Market Analysis – By Product
7.1 Overview
7.2 OTC Drug and Dietary Supplement Revenue Share, by Product (2019 and 2027)
7.3 Cough and Cold Products
7.3.1 Overview
7.3.2 Cough and Cold Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.4 Vitamins and Dietary Supplements
7.4.1 Overview
7.4.2 Vitamins and Dietary Supplements: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.5 Analgesics
7.5.1 Overview
7.5.2 Analgesics: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.6 Gastrointestinal Products
7.6.1 Overview
7.6.2 Gastrointestinal Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.7 Sleep Aids
7.7.1 Overview
7.7.2 Sleep Aids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.8 Oral Care Products
7.8.1 Overview
7.8.2 Oral Care Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.9 Ophthalmic Products
7.9.1 Overview
7.9.2 Ophthalmic Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.10 Antacids
7.10.1 Overview
7.10.2 Antacids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.11 Feminine Care
7.11.1 Overview
7.11.2 Feminine Care: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.12 Others
7.12.1 Overview
7.12.2 Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
8. OTC Drug and Dietary Supplement Analysis – By Type
8.1 Overview
8.2 OTC Drug and Dietary Supplement Revenue Share, by Type (2019 and 2027)
8.3 Branded
8.3.1 Overview
8.3.2 Branded: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
8.4 Generic
8.4.1 Overview
8.4.2 Generic: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9. OTC Drug and Dietary Supplement Analysis – By Form
9.1 Overview
9.2 OTC Drug and Dietary Supplement Share, by Form, 2019 and 2027, (%)
9.3 Tablets
9.3.1 Overview
9.3.2 Tablets: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.4 Capsules
9.4.1 Overview
9.4.2 Capsules: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.5 Powders
9.5.1 Overview
9.5.2 Powders: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.6 Ointments
9.6.1 Overview
9.6.2 Ointments: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.7 Liquid
9.7.1 Overview
9.7.2 Liquid: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
10. OTC Drug and Dietary Supplement Analysis – By Distribution Channel
10.1 Overview
10.2 OTC Drug and Dietary Supplement Share, by Distribution Channel, 2019 and 2027, (%)
10.3 Hospital and Retail Pharmacies
10.3.1 Overview
10.3.2 Hospital and Retail Pharmacies: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
10.4 Retail Stores
10.4.1 Overview
10.4.2 Retail Stores: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
10.5 Online Channels
10.5.1 Overview
10.5.2 Online Channels: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
11. OTC Drug and Dietary Supplement Analysis And Forecasts To 2027 – Geographical Analysis
11.1 Asia Pacific: OTC Drug and Dietary Supplement Market
11.1.1 Overview
11.1.2 Asia-Pacific: OTC Drug and Dietary Supplement Market,- Revenue and Forecast to 2027 (USD Million)
11.1.3 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.4 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.5 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.6 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.7 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
11.1.8 China: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.8.1 China: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.8.2 China: OTC Drug and Dietary Supplement Market,, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.8.3 China: OTC Drug and Dietary Supplement Market,, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.8.4 China: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.8.5 China: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.9 Japan: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Japan: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Japan: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.9.3 Japan: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.9.4 Japan: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.9.5 Japan: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.10 India: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.1 India: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.2 India: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.10.3 India: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.10.4 India: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.10.5 India: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.11 South Korea: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.1.11.1 South Korea: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.1.11.2 South Korea: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.11.3 South Korea: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.11.4 South Korea: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.11.5 South Korea: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.12 Australia: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.1.12.1 Australia: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
11.1.12.2 Australia: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.12.3 Australia: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.12.4 Australia: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.12.5 Australia: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
12. Impact Of COVID-19 Pandemic On Global OTC Drug and Dietary Supplement Market
12.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
13. Company Profiles
13.1 GlaxoSmithKline plc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Sanofi
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Johnson and Johnson Services, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Abbott
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 AbbVie Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bausch Health Companies Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Bayer AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Procter & Gamble
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Novartis AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Reckitt Benckiser Group Plc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 Glossary of Terms, OTC Drug and Dietary Supplement
LIST OF TABLES
Table 1. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 2. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 3. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 4. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 5. China: OTC Drug and Dietary Supplement Market,, by Product – Revenue and Forecast to 2027 (USD Million)
Table 6. China: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 7. China: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 8. China: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 9. Japan: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 10. Japan: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. Japan: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 12. Japan: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. India: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. India: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 15. India: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 16. India: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 17. South Korea OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 18. South Korea OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 19. South Korea: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 20. South Korea: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 21. Australia: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 22. Australia OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 23. Australia: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 24. Australia: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
LIST OF FIGURES
Figure 1. OTC Drug and Dietary Supplement Market Segmentation
Figure 2. OTC Drug and Dietary Supplement Segmentation – By Region
Figure 3. Asia Pacific OTC Drug and Dietary Supplement Market Overview
Figure 4. Analgesics Segment Held Largest Share of OTC Drug and Dietary Supplement
Figure 5. OTC Drug and Dietary Supplement Market in Germany to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific OTC Drug and Dietary Supplement Market- Leading Country Markets (US$ Million)
Figure 7. Asia Pacific PEST Analysis
Figure 8. OTC Drug and Dietary Supplement Impact Analysis Of Driver And Restraints
Figure 9. Asia Pacific OTC Drug and Dietary Supplement Market – Revenue Forecast And Analysis – 2019- 2027
Figure 10. OTC Drug and Dietary Supplement Revenue Share, by Product (2019 and 2027)
Figure 11. Cough and Cold Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Vitamins and Dietary Supplements: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Analgesics: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Gastrointestinal Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Sleep Aids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Oral Care Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Ophthalmic Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Antacids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Feminine Care: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 21. OTC Drug and Dietary Supplement Revenue Share, by Type (2019 and 2027)
Figure 22. Branded: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Generic: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 24. OTC Drug and Dietary Supplement Share, by Form, 2019 and 2027 (%)
Figure 25. Tablets: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Capsules: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Powders: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Ointments: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Liquid: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 30. Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 31. OTC Drug and Dietary Supplement Share, by Distribution Channel, 2019 and 2027 (%)
Figure 32. Hospital and Retail Pharmacies: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 33. Retail Stores: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 34. Online Channels: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 35. Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 36. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Key Country – Revenue (2019) (USD Million)
Figure 37. Asia-Pacific: OTC Drug and Dietary Supplement Market, Revenue and Forecast to 2027 (USD Million)
Figure 38. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
Figure 39. China: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
Figure 40. Japan: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
Figure 41. India: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
Figure 42. South Korea: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)
Figure 43. Australia: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (USD Million)
Figure 44. Impact of COVID-19 Pandemic on OTC Drug And Dietary Supplement Market in Asia Pacifican Countries
- GlaxoSmithKline plc.
- Sanofi
- Johnson and Johnson Services, Inc.
- Abbott
- AbbVie Inc.
- Bausch Health Companies Inc.
- Bayer AG
- Procter & Gamble
- Novartis AG
- Reckitt Benckiser Group Plc
- Saves and reduces time required for carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific OTC drug and dietary supplement market.
- Highlights key business priorities to assist companies in order to realign their business strategies.
- Highlights key findings and recommendations of crucial progressive industry trends in the Asia Pacific OTC drug and dietary supplement market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develops/modifies business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinizes in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhances the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.